DEFINITIVE PROXY STATEMENT

Company

TG THERAPEUTICS, INC.

Filed

April 24, 2013

Period of Report

June 5, 2013

Accession Number

0001144204-13-023634

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →